Petros Pharmaceuticals Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Operating Expenses | 9,267 | 7,591 | 0 | 0 | 0 |
| Operating Income | -9,267 | -7,591 | N/A | N/A | N/A |
| Other Income | 14 | 1 | 0 | 0 | 0 |
| Pre-tax Income | -9,253 | -7,589 | 0 | 0 | 0 |
| Net Income Continuous | -9,253 | -7,589 | N/A | N/A | N/A |
| Net Income | $-9,253 | $-7,589 | $0 | $N/A | $N/A |
| EPS Basic Total Ops | -19,568.69 | -15,974.44 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -16,716.04 | -13,966.05 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -19,568.69 | -15,974.44 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -16,716.04 | -13,966.05 | N/A | N/A | N/A |
| EBITDA(a) | $-9,266 | $-7,591 | $N/A | $N/A | $N/A |